This study shows this loss of mitochondrial function in tumour-infiltrating T-cells is most evident at tumour stage pT3-4 which correlated with the down-regulated expression of PPARGC1A in ccRCC tumours at this stage. This evidence concerns the gene PPARGC1A and nonpapillary renal cell carcinoma.